23 results on '"Clarke, Blaise A."'
Search Results
2. Performance characteristics of brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed ovarian cancers.
3. Comprehensive molecular assessment of mismatch repair deficiency in Lynch-associated ovarian cancers using next-generation sequencing (NGS) panel.
4. A phase Ib trial of pembrolizumab (Pembro) following adoptive cell therapy (ACT) in patients with platinum-resistant ovarian cancer; The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) trial.
5. Phase II clinical and molecular trial of oral ENMD-2076 in clear cell ovarian cancer (CCOC): A study of the Princess Margaret phase II consortium.
6. Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition
7. Germline and somatic homologous recombination gene mutations in high-grade serous ovarian cancer and clinical outcome.
8. P53 functional mutation type in high-grade serous ovarian cancer and clinical outcomes.
9. Integration of somatic molecular profiling for rare epithelial gynaecologic cancer patients.
10. Antitumor activity, safety and predictive biomarker results of ENMD-2076 administered to patients (pts) with recurrent ovarian clear cell carcinoma (OCCC): A trial of the Princess Margaret Phase II Consortium.
11. Incidental germline findings identified in a somatic genomic sequencing program for advanced cancer patients.
12. A phase I/II study of ipilimumab in women with metastatic or recurrent cervical carcinoma: A study of the Princess Margaret and Chicago N01 Consortia.
13. Molecular profiling and targeted therapy in advanced endometrial cancer.
14. Somatic mutation profiling of advanced breast and ovarian cancers according to germline BRCA1/2 mutation status.
15. The CXCL12/CXCR4 pathway, bone marrow-derived myeloid cells, and survival in locally advanced cervical cancer.
16. Adjuvant radiation for patients (pts) with high-grade serous ovarian cancer (HGSC) and T-cell infiltration.
17. Genotype matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).
18. Princess Margaret Cancer Centre (PMCC) Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT) using genotyping and targeted next-generation sequencing (NGS).
19. Screening for Lynch syndrome in unselected women with endometrial cancer.
20. A phase II study of RO4929097 (RO), a gamma-secretase inhibitor, in advanced platinum (Pt)-resistant (R) ovarian cancer (OC): A study of the PMH, Chicago, and California phase II consortia.
21. Brief family history questionnaire for identification of Lynch syndrome in women with newly diagnosed endometrial cancer.
22. Molecular determinants of outcome with mTOR inhibition in endometrial cancer (EC).
23. Prognostic significance of high-risk human papilloma virus (HPV), p16, and p53 status in women with vulvar squamous cell carcinoma (VSCC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.